Sectors
RLMD
Relmada Therapeutics, Inc.
4.47
18 x 4.45
47 x 4.46
bid
ask
-
0.07
1.54%
1 @ 04:00 PM
4.47 +0.00 (0.00%)
| Ytd | -7.45% | |
| 1y | 693.96% |
4.36
day range
4.62
0.56
52 week range
8.00
| Open | 4.55 | Prev Close | 4.54 | Low | 4.36 | High | 4.62 | Mkt Cap | 468.86M |
| Vol | 2.14M | Avg Vol | 1.75M | EPS | -1.09 | P/E | -4.10 | Forward P/E | -0.19 |
| Beta | 0.41 | Short Ratio | 4.52 | Inst. Own | 46.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 6.03 | 200-d Avg | 5.31 | 1yr Est | 0.87 |
| Income Statement | |||
| Operating Expenses | 15.01M | ||
| Research and Development Expense | 8.39M | ||
| Selling, General and Administrative Expense | 6.62M | ||
| Operating Income | -15.01M | ||
| Net Income | -12.91M | ||
| Net Income Common Stock | -12.91M | ||
| Net Income Common Stock (USD) | -12.91M | ||
| Consolidated Income | -12.91M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -12.91M | ||
| Earning Before Interest & Taxes (USD) | -12.91M | ||
| Weighted Average Shares | 112.38M | ||
| Weighted Average Shares Diluted | 112.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.33M | ||
| Cash and Equivalents (USD) | 11.33M | ||
| Investments | 206.40M | ||
| Investments Current | 206.40M | ||
| Trade and Non-Trade Receivables | 10.91K | ||
| Current Assets | 219.04M | ||
| Total Assets | 219.06M | ||
| Current Liabilities | 7.42M | ||
| Total Liabilities | 12.50M | ||
| Accumulated Retained Earnings (Deficit) | -730.23M | ||
| Shareholders Equity | 206.56M | ||
| Shareholders Equity (USD) | 206.56M | ||
| Assets Non-Current | 19.50K | ||
| Liabilities Non-Current | 5.08M | ||
| Trade and Non-Trade Payables | 2.41M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -6.42M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.56M | ||
| Issuance (Purchase) of Equity Shares | -6.36M | ||
| Net Cash Flow from Investing | 17.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 17.59M | ||
| Net Cash Flow from Operations | -9.61M | ||
| Share Based Compensation | 2.24M | ||